Healthcare Services

Angina Market Future Outlook Showing Expansion Toward $14.83 Billion by 2030

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Angina Market Expected To Change Between 2026 And 2030?

The angina market has shown strong growth in recent years. It is expected to rise from $11.36 billion in 2025 to $12.05 billion in 2026 at a CAGR of 6.1%. This growth during the historic period is attributed to the increasing prevalence of cardiovascular diseases, availability of beta blockers and nitrates, expansion of cardiac care units in hospitals, higher rates of diagnostic testing, and the growth of cardiology specialty services.

The angina market is expected to witness strong growth over the next few years, reaching $14.84 billion by 2030 at a CAGR of 5.3%. This growth is supported by increasing demand for personalized cardiovascular treatments, wider use of minimally invasive cardiac procedures, rising adoption of digital cardiac monitoring solutions, expansion of preventive cardiology programs, and ongoing advancements in cardiovascular drug development. Major trends include greater use of combination therapies, increased reliance on long-acting nitrates, stronger emphasis on preventive cardiac care, expansion of interventional treatment options, and heightened focus on lifestyle management and risk reduction.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Which Major Factors Are Driving The Expansion Of The Angina Market?

The growing prevalence of cardiovascular diseases is anticipated to boost the angina market going forward. Cardiovascular diseases include disorders affecting the heart and blood vessels, such as coronary heart disease, heart failure, and stroke. Their increasing prevalence is mainly driven by aging populations and greater exposure to risk factors like unhealthy diets, physical inactivity, and tobacco use. This rise increases the demand for angina treatments, as these conditions often present with chest pain requiring effective management to prevent complications. For instance, in October 2024, the Centers for Disease Control and Prevention, a US-based public health agency, reported that cardiovascular disease deaths rose from 371,506 in 2022 to 919,032 in 2023. Hence, the rising burden of cardiovascular diseases is supporting the growth of the angina market.

How Is The Angina Market Structured Across Different Segments?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Which Trends Are Shaping The Future Of The Angina Market?

Major players in the angina market are focusing on developing innovative medications such as metoprolol tartrate tablets to deliver more targeted and effective treatment for patients with coronary artery disease (CAD) and related conditions. These tablets are widely used to manage cardiovascular conditions such as angina, hypertension, and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, received final approval from the US-FDA to produce and market its generic Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. As a beta blocker, metoprolol helps manage high blood pressure and chest pain while improving survival after heart attacks.

Which Major Players Dominate The Angina Market?

Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd

Read the full angina market report here:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Region Currently Holds The Largest Share Of The Angina Market?

North America was the largest region in the angina market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Angina Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp

Browse Through More Reports Similar to the Global Angina Market 2026, By The Business Research Company

Angina Pectoris Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Angina Pectoris Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Angio Suites Global Market Report

https://www.thebusinessresearchcompany.com/report/angio-suites-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795